First‐in‐human assessment of safety and pharmacokinetics of EP9001A:an anti‐nerve growth factor antibody for chronic pain treatment
Year: 2025
Type: article
Source: British Journal of Pharmacology
DOI: 10.1111/bph.70317
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7117665799
